Genryzon Somatrogon 24mg 60mg Injection NGENLA

Genryzon Somatrogon Injection (NGENLA)Brand Names: Genryzon, NGENLAComposition: SomatrogonStrength: Available as 24 mg/1.2 mL and 60 mg/1.2 mL injectionsManufacturer: PfizerPackaging: Pre-filled syringesTreatment: Growth hormone deficiencyProduct Description:Genryzon Somatrogon (NGENLA) is a long-acting growth hormone injection used to treat growth hormone deficiency in pediatric patients. It helps stimulate growth and manage conditions related to insufficient growth hormone levels. This once-weekly injection offers convenience over daily growth hormone therapies. Somatrogon is a synthetic form of growth hormone designed to promote linear growth in children with growth hormone deficiency.Indications:Pediatric growth hormone deficiencyDosage and Administration:Genryzon is administered once a week via subcutaneous injection, with the dosage adjusted based on the child's weight and response to therapy as directed by a healthcare provider.Common side effects include:Injection site reactionsHeadachesNauseaMuscle pain About the Company Legal Status of Firm: Partnership Number of Employees: 26 To 50 People Annual Turnover: 0 - 40 L company-description: Established in the year of 2024, we "Infiniti International" are Wholesaler, Trader, Retailer, Exporter and Service Provider of an Anti Cancer Medicines, Pharmaceutical Tablets, Pharmaceutical Gel And Cream, Cabergoline Tablet, Finasteride Tablets, Pharmaceutical Capsules, Contraceptives, Pharmaceuticals Injection, Pharmaceutical Eye Drop, Antidiabetic Medicine, Asthma Medicine. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers. For our accomplishment story, we are grateful to our "Mr. Kevin" whose continual backing and direction have been useful to us for attaining exponential development in the current market.